METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Clinical trials for METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE explained in plain language.
Never miss a new study
Get alerted when new METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE trials appear
Sign up with your email to follow new studies for METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Morning vs. evening: finding the best workout time to fight fatty liver
Disease control Not yet recruitingThis study aims to find out if exercising in the morning or evening is more effective for reducing liver fat and improving heart and metabolic health in postmenopausal women with fatty liver disease. It will involve 63 sedentary women who will be assigned to do supervised workout…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: Universidad de Almeria • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Can a simple diet change reverse fatty liver in kids?
Disease control Not yet recruitingThis study is testing two different diet approaches to see which works best to reduce liver fat and improve heart health in teens with fatty liver disease. Researchers will compare a diet low in sugar with a diet rich in essential amino acids. The goal is to find the most effecti…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: PHASE2 • Sponsor: Corewell Health West • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
AI steps in to catch a silent liver threat missed in ER scans
Diagnosis Not yet recruitingThis study tests a new computer tool designed to catch a common but often overlooked finding on emergency room scans: fatty liver disease. The AI system alerts doctors to the finding, provides a risk assessment for the patient, and suggests appropriate follow-up steps. The goal i…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: Northwestern University • Aim: Diagnosis
Last updated Mar 30, 2026 14:32 UTC
-
Could a simple scan replace painful liver biopsies?
Diagnosis Not yet recruitingThis study is testing a new type of ultrasound scan to see if it can accurately detect and measure the severity of fatty liver disease. Researchers will compare the new ultrasound method against current standard tests like MRI and a device called FibroScan in 145 volunteers, incl…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Sponsor: University of British Columbia • Aim: Diagnosis
Last updated Mar 30, 2026 14:29 UTC
-
Simple blood test may warn fatty liver patients of impending heart attack
Knowledge-focused Not yet recruitingThis study aims to find out if a common blood test result, called mean platelet volume (MPV), can help predict which people with fatty liver disease are at high risk for a heart attack. Researchers will compare MPV levels in 60 patients with fatty liver disease, some who have had…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC
-
Scientists test if lowering insulin can fight fatty liver disease
Knowledge-focused Not yet recruitingThis study aims to understand how high insulin levels contribute to fatty liver disease in people who are overweight and insulin resistant. Researchers will temporarily control insulin levels in 36 participants to measure how the liver produces fat and sugar. The goal is to gathe…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: PHASE1 • Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC
-
Scientists create 'Virtual Twins' to predict fatty liver disease risks
Knowledge-focused Not yet recruitingThis study aims to create a detailed computer model, or 'virtual twin,' to better understand how fatty liver disease (MASLD) develops and progresses. Researchers will use existing medical data from over 7,700 patients to train the model to predict the risk of heart problems at di…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Sponsor: Hospital Universitari Vall d'Hebron Research Institute • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:16 UTC